Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-01-24 @ 3:31 AM
Study NCT ID:
NCT01630018
Status:
COMPLETED
Last Update Posted:
2016-09-22
First Post:
2012-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
Sponsor:
Chong Kun Dang Pharmaceutical
Organization: